- Lactoferrin-glycyrrhizin conjugate for tumor targeting therapy

摘要

The present invention relates to a lactoferrin-glycyrrhizin conjugate, which can be used for treatment of brain tumors, skin cancer, lung cancer, etc., which are dependent on angiogenesis, because it can inhibit tumor growth through inhibition of angiogenesis, and is expensive. Since it is a composite that utilizes a low-cost polysaccharide instead of an antibody protein, it is possible to reduce the cost of the drug, thereby reducing the cost of health care, and can be conveniently administered orally.